168 related articles for article (PubMed ID: 35281564)
1. Crystallization of Feline Coronavirus M
Lu J; Chen SA; Khan MB; Brassard R; Arutyunova E; Lamer T; Vuong W; Fischer C; Young HS; Vederas JC; Lemieux MJ
Front Chem; 2022; 10():852210. PubMed ID: 35281564
[TBL] [Abstract][Full Text] [Related]
2. Adaptive Mutation in the Main Protease Cleavage Site of Feline Coronavirus Renders the Virus More Resistant to Main Protease Inhibitors.
Jiao Z; Yan Y; Chen Y; Wang G; Wang X; Li L; Yang M; Hu X; Guo Y; Shi Y; Peng G
J Virol; 2022 Sep; 96(17):e0090722. PubMed ID: 36000844
[TBL] [Abstract][Full Text] [Related]
3. N-Terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 M
Arutyunova E; Khan MB; Fischer C; Lu J; Lamer T; Vuong W; van Belkum MJ; McKay RT; Tyrrell DL; Vederas JC; Young HS; Lemieux MJ
J Mol Biol; 2021 Jun; 433(13):167003. PubMed ID: 33895266
[TBL] [Abstract][Full Text] [Related]
4. Protease inhibitor GC376 for COVID-19: Lessons learned from feline infectious peritonitis.
Sharun K; Tiwari R; Dhama K
Ann Med Surg (Lond); 2021 Jan; 61():122-125. PubMed ID: 33456770
[TBL] [Abstract][Full Text] [Related]
5. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.
Theerawatanasirikul S; Kuo CJ; Phecharat N; Chootip J; Lekcharoensuk C; Lekcharoensuk P
Antiviral Res; 2020 Oct; 182():104927. PubMed ID: 32910955
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of SARS-CoV-2 main protease inhibition by a broad-spectrum anti-coronaviral drug.
Wang YC; Yang WH; Yang CS; Hou MH; Tsai CL; Chou YZ; Hung MC; Chen Y
Am J Cancer Res; 2020; 10(8):2535-2545. PubMed ID: 32905393
[TBL] [Abstract][Full Text] [Related]
7. Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.
Vuong W; Khan MB; Fischer C; Arutyunova E; Lamer T; Shields J; Saffran HA; McKay RT; van Belkum MJ; Joyce MA; Young HS; Tyrrell DL; Vederas JC; Lemieux MJ
Nat Commun; 2020 Aug; 11(1):4282. PubMed ID: 32855413
[TBL] [Abstract][Full Text] [Related]
8. Crystal Structure of Feline Infectious Peritonitis Virus Main Protease in Complex with Synergetic Dual Inhibitors.
Wang F; Chen C; Liu X; Yang K; Xu X; Yang H
J Virol; 2016 Feb; 90(4):1910-7. PubMed ID: 26656689
[TBL] [Abstract][Full Text] [Related]
9. An RNA replicon system to investigate promising inhibitors of feline coronavirus.
Schmied K; Ehmann R; Kristen-Burmann C; Ebert N; Barut GT; Almeida L; Kelly JN; Thomann L; Stalder H; Lang R; Tekes G; Thiel V
J Virol; 2024 Feb; 98(2):e0121623. PubMed ID: 38236006
[TBL] [Abstract][Full Text] [Related]
10. Structural Basis for Coronaviral Main Proteases Inhibition by the 3CLpro Inhibitor GC376.
Lin C; Zhu Z; Jiang H; Zou X; Zeng X; Wang J; Zeng P; Li W; Zhou X; Zhang J; Wang Q; Li J
J Mol Biol; 2024 Mar; 436(6):168474. PubMed ID: 38311236
[TBL] [Abstract][Full Text] [Related]
11. Current status on treatment options for feline infectious peritonitis and SARS-CoV-2 positive cats.
Izes AM; Yu J; Norris JM; Govendir M
Vet Q; 2020 Dec; 40(1):322-330. PubMed ID: 33138721
[TBL] [Abstract][Full Text] [Related]
12. Phylogenetic analysis of feline infectious peritonitis virus, feline enteric coronavirus, and severe acute respiratory syndrome coronavirus 2 of cats in Surabaya, Indonesia.
Aksono EB; Iradatya KR; Sucipto TH; Fajar NS; Yuniarti WM
Vet World; 2023 Jan; 16(1):76-81. PubMed ID: 36855370
[TBL] [Abstract][Full Text] [Related]
13. Broad-spectrum inhibitors against 3C-like proteases of feline coronaviruses and feline caliciviruses.
Kim Y; Shivanna V; Narayanan S; Prior AM; Weerasekara S; Hua DH; Kankanamalage AC; Groutas WC; Chang KO
J Virol; 2015 May; 89(9):4942-50. PubMed ID: 25694593
[TBL] [Abstract][Full Text] [Related]
14. Discovery of M Protease Inhibitors Encoded by SARS-CoV-2.
Hung HC; Ke YY; Huang SY; Huang PN; Kung YA; Chang TY; Yen KJ; Peng TT; Chang SE; Huang CT; Tsai YR; Wu SH; Lee SJ; Lin JH; Liu BS; Sung WC; Shih SR; Chen CT; Hsu JT
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32669265
[TBL] [Abstract][Full Text] [Related]
15. Potent inhibition of feline coronaviruses with peptidyl compounds targeting coronavirus 3C-like protease.
Kim Y; Mandadapu SR; Groutas WC; Chang KO
Antiviral Res; 2013 Feb; 97(2):161-8. PubMed ID: 23219425
[TBL] [Abstract][Full Text] [Related]
16. Better therapeutic effect of oral administration of GS441524 compared with GC376.
Yan Y; Li J; Jiao Z; Yang M; Li L; Wang G; Chen Y; Li M; Shen Z; Shi Y; Peng G
Vet Microbiol; 2023 Aug; 283():109781. PubMed ID: 37269714
[TBL] [Abstract][Full Text] [Related]
17. Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.
Kim Y; Liu H; Galasiti Kankanamalage AC; Weerasekara S; Hua DH; Groutas WC; Chang KO; Pedersen NC
PLoS Pathog; 2016 Mar; 12(3):e1005531. PubMed ID: 27027316
[TBL] [Abstract][Full Text] [Related]
18. Improved SARS-CoV-2 M
Vuong W; Fischer C; Khan MB; van Belkum MJ; Lamer T; Willoughby KD; Lu J; Arutyunova E; Joyce MA; Saffran HA; Shields JA; Young HS; Nieman JA; Tyrrell DL; Lemieux MJ; Vederas JC
Eur J Med Chem; 2021 Oct; 222():113584. PubMed ID: 34118724
[TBL] [Abstract][Full Text] [Related]
19. Mutation in spike protein cleavage site and pathogenesis of feline coronavirus.
Licitra BN; Millet JK; Regan AD; Hamilton BS; Rinaldi VD; Duhamel GE; Whittaker GR
Emerg Infect Dis; 2013 Jul; 19(7):1066-73. PubMed ID: 23763835
[TBL] [Abstract][Full Text] [Related]
20. Establishment of Full-Length cDNA Clones and an Efficient Oral Infection Model for Feline Coronavirus in Cats.
Wang G; Hu G; Liang R; Shi J; Qiu X; Yang Y; Jiao Z; Chen Y; Shen Z; Li M; Shi Y; Mao J; Peng G
J Virol; 2021 Oct; 95(21):e0074521. PubMed ID: 34406859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
